GlassScriptPhysician profile
Cassandra Keady
NPI 1912612193
$1,119.86
in general payments reported to CMS, 2019-2025
23 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $431 · 2024: $432 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $296.21 | 2023-2025 | |
| Abbvie INC. | $110.75 | 2023-2025 | |
| Janssen Biotech, INC. | $69.07 | 2023 | Tecvayli, Darzalex, Talvey |
| Merck Sharp & Dohme LLC | $68.66 | 2023-2024 | Keytruda |
| Regeneron Healthcare Solutions, INC. | $55.77 | 2024 | Libtayo |
| Novartis Pharmaceuticals Corporation | $44.53 | 2023-2025 | |
| Lilly USA, LLC | $42.76 | 2023-2024 | Jaypirca, Verzenio |
| Mirati Therapeutics, INC. | $42.06 | 2023 | Krazati |
| Jazz Pharmaceuticals INC. | $39.47 | 2025 | |
| Medtronic, INC. | $38.10 | 2024 | Ligasure, Valleylab Ft10 |
| Convatec INC. | $37.38 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.66 | 2025 | |
| Kerecis Limited | $28.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tempus Ai, INC | $28.14 | 2024 | Xt Cdx |
| C. R. Bard, INC. & Subsidiaries | $27.29 | 2023 | Arista Ah Flexitip |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $25.37 | 2025 | Lynparza |
| Springworks Therapeutics, INC. | $24.94 | 2024 | Ogsiveo |
| Foundation Medicine, INC. | $22.96 | 2023 | Foundationone Cdx |
| Angiodynamics, INC. | $22.51 | 2025 | Smart Port Ct |
| Alnylam Pharmaceuticals INC. | $19.30 | 2023 | Givlaari |
| Exelixis INC. | $17.02 | 2023 | Cabometyx |
| Glaxosmithkline, LLC. | $14.76 | 2023 | Ojjaara |
| Hologic Sales and Service, LLC | $14.42 | 2024 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Keady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.